Upstate innovation has a larger role to play in New York’s life sciences future

Upstate New York is home to technologies and institutions with clear relevance to the life sciences—from academic research and healthcare systems to advanced manufacturing, semiconductors, optics, and photonics. The opportunity is to help more innovators translate those strengths into new products, companies, and partnerships.

At a recent NextCorps lunch & learn, Jancy Nightingale-Burch, ecosystem development manager at NewYorkBIO, discussed how the statewide life sciences association is helping make that possible. Her message for Upstate founders, researchers, and technology companies was clear: life sciences should not be viewed as a separate or competing sector, but as a growing market for capabilities already being developed across the region.

The opportunity for Upstate New York

NewYorkBIO is the state’s leading life sciences association, representing more than 300 active members across 42 cities. Nearly one-third of its New York members are located outside the New York City metro area, underscoring the breadth of the state’s life sciences ecosystem—and the potential to deepen participation across Upstate.

Rochester and the surrounding region bring particular strengths to that effort. The region’s expertise in optics and photonics, semiconductors, advanced manufacturing, academic research, and healthcare can support applications in medical devices, diagnostics, neuroscience, oncology, and other areas of life sciences innovation.

New York is already among the nation’s leaders in research funding and life sciences investment. But like many growing innovation ecosystems, it faces challenges in moving discoveries from the lab to the market. Access to venture capital, specialized lab space, experienced talent, and commercialization support remains essential.

That transition from early research to a viable company is often called the “valley of death.” Promising science alone is not enough; founders also need the funding, infrastructure, validation, and industry connections required to develop, scale, and commercialize their work.

A statewide resource hub

One tool designed to make those resources more visible is New York Bio Connect, a free statewide platform developed through a partnership among NewYorkBIO, Empire State Development, and the New York City Economic Development Corporation.

Launched in 2025, the platform brings together funding opportunities, life sciences investors, lab and facility space, accelerator and incubator programs, jobs, events, and industry news and reports.

For founders and researchers, the value is straightforward: New York Bio Connect makes it easier to identify resources that may otherwise be dispersed across multiple organizations, websites, and networks. That includes federal, private, and state-level funding, as well as investors with an interest in life sciences companies—an especially important distinction in a sector where technical risk and long development timelines can require specialized funding partners.

The platform is free to use, and NewYorkBIO continues to expand the representation of Upstate companies, facilities, programs, and other resources.

Helping startups preserve capital

NewYorkBIO membership also offers practical benefits that can matter for early-stage companies managing limited budgets. Through affiliation with NewYorkBIO, members can access negotiated pricing on common business and R&D expenses, including laboratory supplies, equipment, and shipping. Collectively, NewYorkBIO members saved approximately $14 million through the program last year. For startups, those savings can help stretch available capital further—preserving resources for research, product development, hiring, and other commercialization priorities.

Members can also access experienced biotech executives for contract and fractional support, along with mentorship, industry events, investor connections, and ways to engage with policymakers.

Because NextCorps is a NewYorkBIO member, eligible companies in the NextCorps business incubator can access those membership benefits without an additional NewYorkBIO membership cost.

A two-way exchange

NewYorkBIO also serves as a bridge among founders, researchers, investors, industry leaders, institutions, and policymakers across the state. For Upstate companies, stronger statewide relationships can create access to investors, customers, mentors, and life sciences infrastructure concentrated in the New York City metro area.

But Nightingale-Burch emphasized that the relationship should not move in only one direction.

Upstate brings complementary assets that deserve greater visibility: advanced manufacturing capacity, optics and photonics expertise, semiconductor capabilities, research institutions, medical centers, and a growing base of technology companies. The goal is not only to connect Upstate founders with Downstate resources, but also to bring investors, industry leaders, and other partners to Rochester and communities across the region to see those capabilities firsthand.

What it means for Upstate innovators

The life sciences economy relies on more than biotech alone. It depends on the tools, technologies, talent, facilities, and partnerships that help researchers and companies solve complex healthcare challenges.

For Rochester and the broader Upstate region, that creates an important opportunity: position existing strengths in manufacturing, photonics, semiconductors, research, and healthcare as essential parts of New York’s life sciences future. With stronger pathways to capital, expertise, infrastructure, and industry relationships, more Upstate innovations can move beyond discovery and toward real-world impact.

Interested in future NextCorps workshops and events? Subscribe to the NextCorps newsletter to stay up to date on upcoming workshops and events.